Ipilimumab in advanced melanoma: added benefit for non-pretreated patients not proven

[:content [\1 \7 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \T \h \e \space \G \e \r \m \a \n \space \I \n \s \t \i \t \u \t \e \space \f \o \r \space \Q \u \a \l \i \t \y \space \a \n \d \space \E \f \f \i \c \i \e \n \c \y \space \i \n \space \H \e \a \l \t \h \space \C \a \r \e \space \( \I \Q \W \i \G \) \space \a \l \r \e \a \d \y \space \a \s \s \e \s \s \e \d \space \t \h \e \space \a \d \d \e \d \space \b \e \n \e \f \i \t \space \o \f " ..."]]
Read more →

Germany tops global patient table for access to medicines

Germany has come top of a new international league table in terms of access to medicines for patient organisations, with ...

Read more →

Germany's IQWiG finds some benefit in Eisai's Halaven (eribulin mesylate)

Germany’s IQWiG has concluded that Eisai’s breast cancer drug Halaven (erbulin mesylate) does indeed offer a benefit over other comparators on ...

Read more →

IQWiG publishes new version of its General Methods [German]

The Institute for Quality and Efficiency in Health Care (IQWiG) has completed the first step of the revision of its ...
Read more →

Gilead agrees price cut for Sovaldi in Germany

Gilead Sciences has finally agreed a price of for its hepatitis C virus (HCV) therapy Sovaldi with Germany's main health ...

Read more →

Ledipasvir plus sofosbuvir: hint of added benefit in further patient group

The German Institute for Quality and Efficiency in Health Care (IQWiG) has assessed documents subsequently submitted by the drug manufacturer ...

Read more →

Additional benefit of idelalisib is not occupied

2 January 2015 - Idelalisib (trade name Zydelig) has been available since September 2014 for use by patients with follicular lymphoma or chronic ...

Read more →

Daclatasvir dihydrochloride for hepatitis C: hint of added benefit in genotype 4

Daclatasvir dihydrochloride (trade name Daklinza) has been approved since August 2014 for the treatment of adults with chronic hepatitis C ...

Read more →

Enzalutamide in prostate cancer: hints of added benefit

5 December 2013 - Enzalutamide (Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the ...
Read more →

Eisai ‘outraged’ by IQWIG’s failure to back epilepsy drug

Japan-based Eisia said it was “outraged” with IQWIG's view that Fycompa (perampanel) offered no additional benefit for epilepsy and should ...

Read more →

Germany extends drug price freeze to end-2017

[:content [\2 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \G \e \r \m \a \n \space \l \e \g \i \s \l \a \t \o \r \s \space \h \a \v \e \space \v \o \t \e \d \space \t \o \space \c \o \n \t \i \n \u \e \space \u \n \t \i \l \space \t \h \e \space \e \n \d \space \o \f \space \2 \0 \1 \7 \space \t \h \e \space \p \r \i \c \e \space \f \r \e \e \z \e \space \o \n \space \r \e \i \m \b \u \r \s \e \d \space \d \r \u \g \s " ..."]]
Read more →

German watchdog deals setback to Bayer eye drug Eylea (aflibercept)

[:content [\2 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \  \- \space \B \a \y \e \r \space \s \u \f \f \e \r \e \d \space \a \space \s \e \t \b \a \c \k \space \i \n \space \i \t \s \space \h \o \m \e \space \m \a \r \k \e \t \space \o \f \space \G \e \r \m \a \n \y \  \o \n \space \T \h \u \r \s \d \a \y \space \w \h \e \n \space \a \space \h \e \a \l \t \h \c \a \r \e \space \c \o \s \t \space \w \a \t \c \h \d \o \g \space \s \a \i \d " ..."]]
Read more →

G-BA confirms that Jetrea (ocriplasmin) has significant added benefit for patients with vitreomacular traction

[:content [\T \h \r \o \m \b \o \G \e \n \i \c \s \space \h \a \s \space \a \n \n \o \u \n \c \e \d \space \t \h \a \t \space \t \h \e \space \F \i \n \a \l \space \E \a \r \l \y \space \B \e \n \e \f \i \t \space \A \s \s \e \s \s \m \e \n \t \space \f \r \o \m \space \t \h \e \space \G \- \B \A \space \h \a \s \space \c \o \n \c \l \u \d \e \d \space \t \h \a \t \space \J \e \t \r \e \a \space \( \o \c \r \i \p \l \a \s \m \i \n \) \space \d \e \m \o \n \s \t \r \a \t \e \s \space \s \i \g \n \i \f \i \c \a \n \t \space \a \d \d \e \d " ..."]]
Read more →

Regorafenib: hint of minor added benefit

[:content [\R \e \g \o \r \a \f \e \n \i \b \space \( \S \t \i \v \a \r \g \a \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \i \n \space \G \e \r \m \a \n \y \space \s \i \n \c \e \space \A \u \g \u \s \t \space \2 \0 \1 \3 \space \f \o \r \space \a \d \u \l \t \s \space \w \i \t \h \space \m \e \t \a \s \t \a \t \i \c \space \c \o \l \o \r \e \c \t \a \l \space \c \a \n \c \e \r \space \i \n \space \w \h \o \m \space \p \r \e \v \i \o \u \s \space \t \r \e \a \t \m \e \n \t \s " ..."]]
Read more →

Nalmefene for alcohol dependence: added benefit not proven

Nalmefene (trade name Selincro) has been approved since February 2013 for people with alcohol dependence who currently drink a lot ...

Read more →